These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 18163422

  • 1. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A.
    Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X, Zhang J, Wang L, Wei H, Tian Z.
    BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579
    [Abstract] [Full Text] [Related]

  • 4. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.
    Yang Y, Ikezoe T, Takeuchi T, Adachi Y, Ohtsuki Y, Koeffler HP, Taguchi H.
    Oncol Rep; 2006 Jun 04; 15(6):1581-90. PubMed ID: 16685399
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO, Lou W, Johnson CS, Trump DL, Gao AC.
    Prostate; 2004 Aug 01; 60(3):178-86. PubMed ID: 15176047
    [Abstract] [Full Text] [Related]

  • 6. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines.
    Sumita N, Bito T, Nakajima K, Nishigori C.
    Exp Dermatol; 2006 Apr 01; 15(4):291-9. PubMed ID: 16512876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway.
    Lee JH, Schütte D, Wulf G, Füzesi L, Radzun HJ, Schweyer S, Engel W, Nayernia K.
    Hum Mol Genet; 2006 Jan 15; 15(2):201-11. PubMed ID: 16377660
    [Abstract] [Full Text] [Related]

  • 10. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):1190-7. PubMed ID: 10741751
    [Abstract] [Full Text] [Related]

  • 11. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
    Canesin G, Evans-Axelsson S, Hellsten R, Sterner O, Krzyzanowska A, Andersson T, Bjartell A.
    Eur Urol; 2016 Mar 15; 69(3):400-4. PubMed ID: 26144873
    [Abstract] [Full Text] [Related]

  • 12. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
    Lee SO, Dutt SS, Nadiminty N, Pinder E, Liao H, Gao AC.
    Prostate; 2007 Sep 01; 67(12):1293-300. PubMed ID: 17626246
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells.
    Pu YS, Hour TC, Chuang SE, Cheng AL, Lai MK, Kuo ML.
    Prostate; 2004 Jul 01; 60(2):120-9. PubMed ID: 15162378
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N.
    Int J Oncol; 2007 Jul 01; 31(1):129-36. PubMed ID: 17549413
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
    Angelucci C, Iacopino F, Lama G, Capucci S, Zelano G, Boca M, Pistilli A, Sica G.
    Anticancer Res; 2004 Jul 01; 24(5A):2729-38. PubMed ID: 15517879
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 17. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M, Schally AV, Szepeshazi K, Halmos G, Nagy A.
    Clin Cancer Res; 2003 Oct 01; 9(12):4505-13. PubMed ID: 14555524
    [Abstract] [Full Text] [Related]

  • 18. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
    Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, Kondo S, Priebe W, Kondo Y.
    Oncogene; 2007 Apr 12; 26(17):2435-44. PubMed ID: 17043651
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR, Oldenkamp JR, London CA, Iversen PL.
    Prostate; 2002 Nov 01; 53(3):200-10. PubMed ID: 12386920
    [Abstract] [Full Text] [Related]

  • 20. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
    Ma XT, Wang S, Ye YJ, Du RY, Cui ZR.
    Ai Zheng; 2003 Nov 01; 22(11):1135-9. PubMed ID: 14613639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.